These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29389577)

  • 1. Urine specimen validity test for drug abuse testing in workplace and court settings.
    Lin SY; Lee HH; Lee JF; Chen BH
    J Food Drug Anal; 2018 Jan; 26(1):380-384. PubMed ID: 29389577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on alcohol & drug abuse: ensuring validity in urine drug testing.
    Jaffee WB; Trucco E; Teter C; Levy S; Weiss RD
    Psychiatr Serv; 2008 Feb; 59(2):140-2. PubMed ID: 18245154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
    Kirsh KL; Christo PJ; Heit H; Steffel K; Passik SD
    J Opioid Manag; 2015; 11(1):53-9. PubMed ID: 25750165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
    Dale RC; Ford LT; Street C
    Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary comparative study on the usefulness of instant-view'TM M-1 and Triage DOA in testing for drugs-of-abuse in forensic urine samples].
    Moriya F
    Chudoku Kenkyu; 2012 Sep; 25(3):243-6. PubMed ID: 23057404
    [No Abstract]   [Full Text] [Related]  

  • 9. The defined HHS/DOT substituted urine criteria validated through a controlled hydration study.
    Edgell K; Caplan YH; Glass LR; Cook JD
    J Anal Toxicol; 2002 Oct; 26(7):419-23. PubMed ID: 12422995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beating the system: a study of a creatinine assay and its efficacy in authenticating human urine specimens.
    Villena VP
    J Anal Toxicol; 2010; 34(1):39-44. PubMed ID: 20109301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures for transportation workplace drug and alcohol testing programs. Final rule.
    Office of the Secretary, DOT
    Fed Regist; 2008 Jun; 73(123):35961-75. PubMed ID: 18677826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization of human urine for specimen validity determination in workplace drug testing: a review.
    Cook JD; Caplan YH; LoDico CP; Bush DM
    J Anal Toxicol; 2000 Oct; 24(7):579-88. PubMed ID: 11043663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
    Busardò FP; Jones AW
    Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive GC-EIMS method for simultaneous detection and quantification of JWH-018 and JWH-073 carboxylic acid and hydroxy metabolites in urine.
    Paul BD; Bosy T
    J Anal Toxicol; 2015 Apr; 39(3):172-82. PubMed ID: 25691387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.